Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Well-defined, size-tunable, multifunctional micelles for efficient paclitaxel delivery for cancer treatment.

Luo J, Xiao K, Li Y, Lee JS, Shi L, Tan YH, Xing L, Holland Cheng R, Liu GY, Lam KS.

Bioconjug Chem. 2010 Jul 21;21(7):1216-24. doi: 10.1021/bc1000033.

2.

A novel size-tunable nanocarrier system for targeted anticancer drug delivery.

Li Y, Xiao K, Luo J, Lee J, Pan S, Lam KS.

J Control Release. 2010 Jun 15;144(3):314-23. doi: 10.1016/j.jconrel.2010.02.027. Epub 2010 Mar 6.

3.

PEG-oligocholic acid telodendrimer micelles for the targeted delivery of doxorubicin to B-cell lymphoma.

Xiao K, Luo J, Li Y, Lee JS, Fung G, Lam KS.

J Control Release. 2011 Oct 30;155(2):272-81. doi: 10.1016/j.jconrel.2011.07.018. Epub 2011 Jul 19.

4.

Free paclitaxel loaded PEGylated-paclitaxel nanoparticles: preparation and comparison with other paclitaxel systems in vitro and in vivo.

Lu J, Chuan X, Zhang H, Dai W, Wang X, Wang X, Zhang Q.

Int J Pharm. 2014 Aug 25;471(1-2):525-35. doi: 10.1016/j.ijpharm.2014.05.032. Epub 2014 May 22.

PMID:
24858391
5.

A self-assembling nanoparticle for paclitaxel delivery in ovarian cancer.

Xiao K, Luo J, Fowler WL, Li Y, Lee JS, Xing L, Cheng RH, Wang L, Lam KS.

Biomaterials. 2009 Oct;30(30):6006-16. doi: 10.1016/j.biomaterials.2009.07.015. Epub 2009 Aug 5.

6.

Well-defined, reversible disulfide cross-linked micelles for on-demand paclitaxel delivery.

Li Y, Xiao K, Luo J, Xiao W, Lee JS, Gonik AM, Kato J, Dong TA, Lam KS.

Biomaterials. 2011 Sep;32(27):6633-45. doi: 10.1016/j.biomaterials.2011.05.050. Epub 2011 Jun 11.

7.

Biological evaluation of redox-sensitive micelles based on hyaluronic acid-deoxycholic acid conjugates for tumor-specific delivery of paclitaxel.

Li J, Yin T, Wang L, Yin L, Zhou J, Huo M.

Int J Pharm. 2015 Apr 10;483(1-2):38-48. doi: 10.1016/j.ijpharm.2015.02.002. Epub 2015 Feb 2.

PMID:
25655715
8.

[Preparation and properties of self-assemble paclitaxel-loaded core-shell type nano-micelles].

Yu Q, Pan SR, Du Z.

Yao Xue Xue Bao. 2008 Apr;43(4):408-14. Chinese.

PMID:
18664205
9.

Fine-tuning vitamin E-containing telodendrimers for efficient delivery of gambogic acid in colon cancer treatment.

Huang W, Wang X, Shi C, Guo D, Xu G, Wang L, Bodman A, Luo J.

Mol Pharm. 2015 Apr 6;12(4):1216-29. doi: 10.1021/acs.molpharmaceut.5b00051. Epub 2015 Mar 2.

PMID:
25692376
10.

Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.

Zhan C, Gu B, Xie C, Li J, Liu Y, Lu W.

J Control Release. 2010 Apr 2;143(1):136-42. doi: 10.1016/j.jconrel.2009.12.020. Epub 2010 Jan 7.

PMID:
20056123
11.

"OA02" peptide facilitates the precise targeting of paclitaxel-loaded micellar nanoparticles to ovarian cancer in vivo.

Xiao K, Li Y, Lee JS, Gonik AM, Dong T, Fung G, Sanchez E, Xing L, Cheng HR, Luo J, Lam KS.

Cancer Res. 2012 Apr 15;72(8):2100-10. doi: 10.1158/0008-5472.CAN-11-3883. Epub 2012 Mar 6.

12.

Linear-dendritic copolymer composed of polyethylene glycol and all-trans-retinoic acid as drug delivery platform for paclitaxel against breast cancer.

Li J, Jiang X, Guo Y, An S, Kuang Y, Ma H, He X, Jiang C.

Bioconjug Chem. 2015 Mar 18;26(3):418-26. doi: 10.1021/acs.bioconjchem.5b00030. Epub 2015 Feb 12.

PMID:
25675244
13.

A structure-property relationship study of the well-defined telodendrimers to improve hemocompatibility of nanocarriers for anticancer drug delivery.

Shi C, Yuan D, Nangia S, Xu G, Lam KS, Luo J.

Langmuir. 2014 Jun 17;30(23):6878-88. doi: 10.1021/la5003513. Epub 2014 Jun 5.

14.

Deoxycholic acid-modified chitooligosaccharide/mPEG-PDLLA mixed micelles loaded with paclitaxel for enhanced antitumor efficacy.

Jiang C, Wang H, Zhang X, Sun Z, Wang F, Cheng J, Xie H, Yu B, Zhou L.

Int J Pharm. 2014 Nov 20;475(1-2):60-8. doi: 10.1016/j.ijpharm.2014.08.037. Epub 2014 Aug 23.

PMID:
25152167
15.

PEG-derivatized embelin as a dual functional carrier for the delivery of paclitaxel.

Huang Y, Lu J, Gao X, Li J, Zhao W, Sun M, Stolz DB, Venkataramanan R, Rohan LC, Li S.

Bioconjug Chem. 2012 Jul 18;23(7):1443-51. doi: 10.1021/bc3000468. Epub 2012 Jun 20.

16.

Thermosensitive and biodegradable polymeric micelles for paclitaxel delivery.

Soga O, van Nostrum CF, Fens M, Rijcken CJ, Schiffelers RM, Storm G, Hennink WE.

J Control Release. 2005 Mar 21;103(2):341-53.

PMID:
15763618
17.

PEG-derivatized octacosanol as micellar carrier for paclitaxel delivery.

Chu B, Qu Y, Huang Y, Zhang L, Chen X, Long C, He Y, Ou C, Qian Z.

Int J Pharm. 2016 Mar 16;500(1-2):345-59. doi: 10.1016/j.ijpharm.2016.01.030. Epub 2016 Jan 18.

PMID:
26794876
18.

Well-Defined Redox-Sensitive Polyethene Glycol-Paclitaxel Prodrug Conjugate for Tumor-Specific Delivery of Paclitaxel Using Octreotide for Tumor Targeting.

Yin T, Wu Q, Wang L, Yin L, Zhou J, Huo M.

Mol Pharm. 2015 Aug 3;12(8):3020-31. doi: 10.1021/acs.molpharmaceut.5b00280. Epub 2015 Jun 30.

PMID:
26086430
19.

Hydrophobically modified inulin as an amphiphilic carbohydrate polymer for micellar delivery of paclitaxel for intravenous route.

Muley P, Kumar S, El Kourati F, Kesharwani SS, Tummala H.

Int J Pharm. 2016 Mar 16;500(1-2):32-41. doi: 10.1016/j.ijpharm.2016.01.005. Epub 2016 Jan 11.

PMID:
26792170
20.

Supplemental Content

Support Center